Leadership Transition at ADMA Biologics
ADMA Biologics, Inc. (Nasdaq: ADMA), a leading end-to-end commercial biopharmaceutical entity, disclosed a significant leadership change today. Brian Lenz, who currently serves as Executive Vice President, Chief Financial Officer & General Manager of ADMA BioCenters, will be transitioning from these roles to a consulting capacity, effective April 1, 2024. In...